CETRELIMAB: 24 Adverse Event Reports & Safety Profile
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
24
Total FAERS Reports
2 (8.3%)
Deaths Reported
21
Hospitalizations
24
As Primary/Secondary Suspect
4
Life-Threatening
First Report: 20180811 · Latest Report: 20230206
What Are the Most Common CETRELIMAB Side Effects?
#1 Most Reported
Neutropenia
3 reports (12.5%)
#2 Most Reported
Anaemia
3 reports (12.5%)
#3 Most Reported
Rash maculo-papular
2 reports (8.3%)
All CETRELIMAB Side Effects by Frequency
No side effect data available.
Who Reports CETRELIMAB Side Effects? Age & Gender Data
Gender: 27.3% female, 72.7% male. Average age: 67.0 years. Most reports from: US. View detailed demographics →
Is CETRELIMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 2 | 0 | 2 |
| 2019 | 7 | 0 | 7 |
| 2020 | 5 | 1 | 3 |
| 2021 | 1 | 0 | 1 |
| 2022 | 4 | 0 | 4 |
| 2023 | 3 | 1 | 3 |
What Is CETRELIMAB Used For?
| Indication | Reports |
|---|---|
| Prostate cancer | 9 |
| Prostate cancer metastatic | 7 |
| Transitional cell carcinoma | 5 |
Official FDA Label for CETRELIMAB
Official prescribing information from the FDA-approved drug label.